Who owns ENLIVEN THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Enliven Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Enliven Therapeutics stock

Who bought or sold ENLIVEN THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
OrbiMed Advisors 8.0M $203M 0% Sep 2024
 View chart
Commodore Capital 4.1M $105M 3% Sep 2024
 View chart
VR Adviser 4.0M $103M 0% Sep 2024
 View chart
Fairmount Funds Management 3.2M $82M 0% Sep 2024
 View chart
BlackRock 2.9M $75M 100% Sep 2024
 View chart
BlackRock 2.7M $64M 51% Jun 2024
 View chart
Vanguard Group 1.8M $43M 54% Jun 2024
 View chart
5AM Venture Management 1.8M $45M -33% Sep 2024
 View chart
Citadel Advisors 1.7M $44M -25% Sep 2024
 View chart
RA Capital Management 1.1M $27M -50% Sep 2024
 View chart
Pictet Asset Management Holding SA 836k $21M 100% Sep 2024
 View chart
Woodline Partners 806k $21M 12% Sep 2024
 View chart
Soleus Capital Management 769k $18M 100% Jun 2024
 View chart
Geode Capital Management 750k $19M 10% Sep 2024
 View chart
Henderson Group 729k $17M 2% Jun 2024
 View chart
State Street Corporation 725k $17M 47% Jun 2024
 View chart
Boxer Capital 671k $17M 0% Sep 2024
 View chart
Logos Global Management 595k $14M -62% Jun 2024
 View chart
First Turn Management 535k $14M 100% Sep 2024
 View chart
Ikarian Capital 500k $13M -15% Sep 2024
 View chart
Rock Springs Capital Management 429k $10M 0% Jun 2024
 View chart
Blackstone Group 373k $9.5M 16% Sep 2024
 View chart
Northern Trust 304k $7.8M 39% Sep 2024
 View chart
Charles Schwab Investment Management 255k $6.5M 10% Sep 2024
 View chart
Cutter Capital Management 208k $5.3M -7% Sep 2024
 View chart
Nicholas Investments Partners 174k $4.4M 100% Sep 2024
 View chart
Saturn V Capital Management 152k $3.6M 100% Jun 2024
 View chart
Marshall Wace 138k $3.5M -28% Sep 2024
 View chart
Nuveen Asset Management 128k $3.0M 54% Jun 2024
 View chart
Baker Bros. Advisors 115k $2.9M 0% Sep 2024
 View chart
Patient Square Capital 91k $2.3M 100% Sep 2024
 View chart
Bank of New York Mellon 90k $2.3M -21% Sep 2024
 View chart
Morgan Stanley 68k $1.6M 8% Jun 2024
 View chart
Goldman Sachs Group 66k $1.5M 281% Jun 2024
 View chart
Barclays 56k $1.4M 296% Sep 2024
 View chart
Rhumbline Advisers 50k $1.3M 0% Sep 2024
 View chart
Bank of America Corporation 49k $1.2M 42% Sep 2024
 View chart
Alliancebernstein 37k $861k 130% Jun 2024
 View chart
Swiss National Bank 37k $939k 0% Sep 2024
 View chart
Cantor Fitzgerald, L. P. 33k $845k 100% Sep 2024
 View chart
Jane Street 31k $787k -42% Sep 2024
 View chart
Citigroup 29k $737k 173% Sep 2024
 View chart
New York State Common Retirement Fund 28k $703k 19% Sep 2024
 View chart
Quest Partners 21k $539k 1226% Sep 2024
 View chart
Jpmorgan Chase & Co 21k $531k 0% Sep 2024
 View chart
MetLife Investment Advisors 21k $523k 0% Sep 2024
 View chart
Franklin Resources 20k $559k 100% Sep 2024
 View chart
Deutsche Bank Aktiengesellschaft 20k $514k 32% Sep 2024
 View chart
Mirae Asset Global Etfs Holdings 19k $493k 70% Sep 2024
 View chart
California State Teachers Retirement System 19k $485k -3% Sep 2024
 View chart
Toroso Investments 18k $411k 100% Jun 2024
 View chart
Voloridge Investment Management 17k $442k 49% Sep 2024
 View chart
Two Sigma Investments 17k $403k 100% Jun 2024
 View chart
Legato Capital Management 15k $372k 100% Sep 2024
 View chart
Invesco 15k $372k 2% Sep 2024
 View chart
Manufacturers Life Insurance Company 14k $322k 100% Jun 2024
 View chart
T. Rowe Price Associates 12k $298k 4% Sep 2024
 View chart
Ing Investment Management 12k $298k -2% Sep 2024
 View chart
Alpine Partners VI 11k $262k 100% Jun 2024
 View chart
Wells Fargo & Company 11k $284k -3% Sep 2024
 View chart
Florida State Board of Administration 11k $268k 0% Sep 2024
 View chart
SG Americas Securities 10k $256k 100% Sep 2024
 View chart
China Universal Asset Management 9.1k $232k 64% Sep 2024
 View chart
Graham Capital Management 9.1k $232k 100% Sep 2024
 View chart
Exchange Traded Concepts 7.5k $191k -60% Sep 2024
 View chart
Royal Bank of Canada 3.8k $94k 11% Sep 2024
 View chart
Summit Investment Advisors 3.4k $88k 0% Sep 2024
 View chart
Tower Research Capital 3.2k $76k 541% Jun 2024
 View chart
Acadian Asset Management 1.8k $46k 100% Sep 2024
 View chart
Mirae Asset Global Investments 1.7k $41k 22% Sep 2024
 View chart
Russell Investments 1.4k $34k 11883% Jun 2024
 View chart
Amalgamated Bank 1.2k $31k 0% Sep 2024
 View chart
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 1.2k $31k 100% Sep 2024
 View chart
NISA Investment Advisors 662.00 $17k 1104% Sep 2024
 View chart
Capital Advisors 302.00 $8.0k 0% Sep 2024
 View chart
Daiwa Securities Group 152.00 $4.0k 0% Sep 2024
 View chart
SRS Capital Advisors 103.00 $2.6k 0% Sep 2024
 View chart
Versant Capital Management 67.00 $1.7k 100% Sep 2024
 View chart
GAMMA Investing 66.00 $1.7k 35% Sep 2024
 View chart
Quarry 52.00 $1.2k 100% Jun 2024
 View chart
Bessemer 45.00 $999.999000 100% Sep 2024
 View chart
Sterling Capital Management 40.00 $1.0k 100% Sep 2024
 View chart
Rothschild Investment 35.00 $894.001500 600% Sep 2024
 View chart
Capital Performance Advisors 32.00 $816.998400 100% Sep 2024
 View chart
CWM 12.00 $0 71% Sep 2024
 View chart
Farther Finance Advisors 6.00 $153.000000 0% Sep 2024
 View chart
Covestor 6.00 $0 0% Sep 2024
 View chart
National Bank Of Canada /fi/ 1.00 $26.000000 100% Sep 2024
 View chart

Who sold out of Enliven Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Exome Asset Management Mar 2024 58k $1.0M
American Century Companies Jun 2024 28k $646k
Susquehanna International Jun 2024 8.7k $203k
Advisor Group Holdings Mar 2024 2.0k $35k
Meeder Asset Management Jun 2024 447.00 $10k
EntryPoint Capital Jun 2024 241.00 $5.6k
Simplex Trading Jun 2024 93.00 $2.0k